10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001213900-18-001597`
Period End Date	20171231
Filing Date	20180212
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	rlmd-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 47 Cash Flow Statement 60

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	-	USD	Point-in-time
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	$6.11M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$232.60K	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	$59.32K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	$61.85K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$240.45K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$472.49K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.47M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.24M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.53M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$2.31K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$3.78K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.55M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.55M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$21.96K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$21.96K	USD	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	$337.73K	USD	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	$306.16K	USD	Point-in-time
Total assets	`Assets`	$6.57M	USD	Point-in-time
Total assets	`Assets`	$2.84M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$529.56K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$286.06K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$394.56K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$494.10K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$276.67K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$111.23K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$175.85K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$3.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.38M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.57M	USD	Point-in-time
Promissory notes payable, net of discount of $6,105,078 and $0	`LongTermNotesPayable`	$1.28M	USD	Point-in-time
Promissory notes payable, net of discount of $6,105,078 and $0	`LongTermNotesPayable`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$5.85M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.38M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,545,120 and 12,528,374 shares issued and outstanding, respectively	`CommonStockValue`	$12.54K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,545,120 and 12,528,374 shares issued and outstanding, respectively	`CommonStockValue`	$12.53K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.50M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-87.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.38M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$721.16K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.46M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.57M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$2.84M	USD	Point-in-time

Income Statement 47 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$150.72K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$254.10K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$618.26K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$316.47K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.31M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.12M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.28M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.53M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$3.15M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$1.46M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$2.44M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$1.54M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-2.44M	USD	2 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-1.46M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-1.54M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-3.15M	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$449.04K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$341.11K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$335.40K	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$369.00K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$-309.35K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$-378.00	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$-1.23K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$-311.87K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$56.91K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$113.82K	USD	2 Qtrs
Other income	`OtherNonoperatingIncome`	$2.35K	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$28.41K	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$505.57K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$481.59K	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$29.23K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.41M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.67M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.43M	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.19	USD	2 Qtrs
Loss per common share - basic	`EarningsPerShareBasic`	$-0.11	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.22	USD	2 Qtrs
Loss per common share - basic	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.19	USD	2 Qtrs
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.11	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	2 Qtrs
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.54M	shares	2 Qtrs
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.04M	shares	2 Qtrs
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.04M	shares	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.55M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.41M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.67M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.43M	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.13K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$43.74K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$304.02K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$202.91K	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-335.40K	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-369.00K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$207.78K	USD	2 Qtrs
Deferred rent liability	`IncreaseDecreaseInDeferredLiabilities`	$-3.84K	USD	2 Qtrs
Deferred rent liability	`IncreaseDecreaseInDeferredLiabilities`	-	USD	2 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-232.60K	USD	2 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	-	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	$-29.04K	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	-	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-232.04K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-216.31K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-322.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-952.48K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$50.27K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-162.37K	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.11M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.60M	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$27.26K	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$2.59K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.59K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-27.26K	USD	2 Qtrs
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	-	USD	2 Qtrs
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	$6.51M	USD	2 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$163.64K	USD	2 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$165.44K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-163.64K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.34M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.79M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.23M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.71M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.71M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Interest	`InterestPaidNet`	$2.23K	USD	2 Qtrs
Interest	`InterestPaidNet`	$2.13K	USD	2 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	$17.00	USD	2 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	-	USD	2 Qtrs
Warrants issued to placement agent	`WarrantsIssuedToPlacementAgent`	-	USD	2 Qtrs
Warrants issued to placement agent	`WarrantsIssuedToPlacementAgent`	$200.66K	USD	2 Qtrs
Warrants issued to promissory note holders	`WarrantsIssuedToPromissoryNoteHolders`	-	USD	2 Qtrs
Warrants issued to promissory note holders	`WarrantsIssuedToPromissoryNoteHolders`	$1.27M	USD	2 Qtrs
Derivative liabilities associated with issuance of promissory notes	`DerivativeLiabilitiesAssociatedWithIssuanceOfPromissoryNotes`	-	USD	2 Qtrs
Derivative liabilities associated with issuance of promissory notes	`DerivativeLiabilitiesAssociatedWithIssuanceOfPromissoryNotes`	$3.84M	USD	2 Qtrs
Accrued financing fees	`AccruedFinancingFees`	$127.76K	USD	2 Qtrs
Accrued financing fees	`AccruedFinancingFees`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.